Status:
COMPLETED
Clinical Tumor Anemia Registry (TAR)
Lead Sponsor:
iOMEDICO AG
Collaborating Sponsors:
ASORS (Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin der Deutschen Krebsgesellschaft)
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry is to record information of routine treatment of anemia in cancer patients in Germany. An overview of the current treatment of anemia in German outpatient centers and hosp...
Eligibility Criteria
Inclusion
- Histologically confirmed malignant disease
- Hemoglobin level \< 11 g/dl (female) or \< 12 g/dl (male)
- Start of antianemic therapy no more than 7 days prior to informed consent
- Performance status 0 - 3 (Karnofsky-Index \>= 40%)
- Minimum age: 18 years
- Informed written consent
Exclusion
- Hypersensitivity against antianemic therapies
- Myelodysplastic Syndrome
- Experimental antianemic therapy
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
1018 Patients enrolled
Trial Details
Trial ID
NCT01795690
Start Date
December 1 2011
End Date
February 1 2016
Last Update
February 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
iOMEDICO
Freiburg im Breisgau, Germany, 79108